Video Experimental Relacionado
Updated: Jul 14, 2026
07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
La síntesis de endotelina-1 reducida por el vino tinto
R Corder1, J A Douthwaite, D M Lees
1William Harvey Research Institute, Barts & the London School of Medicine & Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK. r.corder@qmul.ac.uk
Nature
|January 10, 2002
Resumen
El consumo de vino tinto puede proteger contra la enfermedad coronaria al inhibir la síntesis de endotelina-1. Si bien la ingesta moderada de alcohol ofrece beneficios, los componentes específicos del vino tinto muestran potencial para prevenir la aterosclerosis coronaria.
Área de la Ciencia:
- Ciencias Cardiovasculares Ciencias Cardiovasculares
- Bioquímica nutricional y nutrición.
Sus antecedentes:
- Existen vínculos estadísticos entre el alto consumo de vino y la reducción de la enfermedad coronaria.
- El consumo moderado de alcohol se asocia con una menor incidencia de enfermedad coronaria.
- La evidencia de que el vino tinto proporciona beneficios cardiovasculares adicionales más allá del alcohol general es limitada.
Objetivo del estudio:
- Investigar los mecanismos específicos por los cuales el vino tinto puede afectar la enfermedad coronaria.
- Para determinar si los componentes únicos del vino tinto ofrecen un efecto protector contra las enfermedades cardiovasculares.
Principales métodos:
- Evaluación del efecto de los vinos tintos en la síntesis de endotelina-1.
- Evaluar la endotelina-1 como un péptido clave en el desarrollo de la aterosclerosis coronaria.
Principales resultados:
- Se descubrió que los vinos tintos inhiben fuertemente la síntesis de endotelina-1.
- La endotelina-1 juega un papel crucial en el desarrollo de la aterosclerosis coronaria.
Conclusiones:
- Los componentes específicos del vino tinto demuestran una capacidad para inhibir la síntesis de endotelina-1.
- Estos hallazgos sugieren un mecanismo potencial para el vino tinto en la prevención de la enfermedad coronaria.
Videos de Conceptos Relacionados
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...